{
    "eid": "2-s2.0-85103205561",
    "title": "DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice",
    "cover-date": "2021-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Eakachai Prompetchara",
        "Chutitorn Ketloy",
        "Kittipan Tharakhet",
        "Papatsara Kaewpang",
        "Supranee Buranapraditkun",
        "Teerasit Techawiwattanaboon",
        "Suwitra Sathean-Anan-kun",
        "Patrawadee Pitakpolrat",
        "Supaporn Watcharaplueksadee",
        "Supaporn Phumiamorn",
        "Wassana Wijagkanalan",
        "Kanitha Patarakul",
        "Tanapat Palaga",
        "Kiat Ruxrungtham"
    ],
    "citedby-count": 23,
    "ref-count": 61,
    "ref-list": [
        "The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control",
        "Developing Covid-19 Vaccines at Pandemic Speed",
        "COVID-19 Vaccine: A comprehensive status report",
        "Next-generation vaccine platforms for COVID-19",
        "Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic",
        "Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development",
        "Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies",
        "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein",
        "Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults",
        "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults",
        "An mRNA Vaccine against SARS-CoV-2-Preliminary Report",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial",
        "Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine",
        "DNA vaccines: Roles against diseases",
        "Rapid COVID-19 vaccine development",
        "Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines",
        "Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine",
        "DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge",
        "Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines",
        "Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness",
        "Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates",
        "ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques",
        "RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study",
        "SARS-CoV-2 vaccines in development",
        "Rapid-response vaccines-does DNA offer a solution?",
        "The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens",
        "A neutralizing human antibody binds to the Nterminal domain of the Spike protein of SARS-CoV-2",
        "Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma",
        "Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients",
        "SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen",
        "Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates",
        "A thermostable, closed SARSCoV-2 spike protein trimer",
        "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion",
        "Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients",
        "Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19",
        "Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals",
        "T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice",
        "A candidate multi-epitope vaccine against SARS-CoV-2",
        "Mining of epitopes on spike protein of SARSCoV-2 from COVID-19 patients",
        "Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus",
        "Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus",
        "A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge",
        "A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein",
        "Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus",
        "Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine",
        "A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice",
        "The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement",
        "Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate",
        "Immunogenicity of a DNA vaccine candidate for COVID-19",
        "DNA vaccine protection against SARS-CoV-2 in rhesus macaques",
        "Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial",
        "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",
        "SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "111805699",
            "affilname": "BioNet-Asia Co.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/111805699",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}